Skip to main content

Table 1 Anti-HBs titres in preS1 (21–32, 32–47 and 94–117) reactive sera compared with non-reactive sera from newborns vaccinated with Bio-HepB™ vaccine

From: PreS1 epitope recognition in newborns after vaccination with the third-generation Sci-B-Vac™ vaccine and their relation to the antibody response to hepatitis B surface antigen

 

Reactive

Non-reactive

Probability

Anti-preS1 (21–32)

n = 14

n = 14

 

Anti-HBs IU/L

15 841 ± 4 023

16 026 ± 7 859

ns

Anti-preS1 (32–47)

n = 15

n = 13

 

Anti-HBs IU/L

24 550 ± 7 375

5 991 ± 1 530

p < 0.05

Anti-preS1 (94–117)

n = 12

n = 16

 

Anti-HBs IU/L

19 464 ± 5 280

13 286 ± 6 533

ns

  1. ns = not significant
  2. Anti-HBs (mean ± SEM)